What You Should Know:
- Kelonia Therapeutics, a Boston-based biotech company focused on vivo gene delivery, launched with a $50 million in Series A funding to expand the benefit and reach of genetic medicines.
- Despite life-changing responses, existing gene therapies are highly complex, costly, and limited by complicated treatment paradigms, tractable therapeutic applications, and dose-limiting toxicities. By enabling precisely targeted, highly efficient, manufacturable “off-the-shelf” in
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
3 Keys to Eliminating Data Breakdowns in Life Sciences
Across life sciences, experts boldly predict that data is the new currency—and that mobilizing data from clinical trials, wearable devices and even social media will ignite innovation in 2022. But leveraging data for innovation depends not just on data analytics, but also access to the right data and timely analysis.
As the amount of data that life sciences experts have at their fingertips explodes, with leaders tapping into real-world evidence from smartphone apps, wearable devices and
Read More
3 Predictions for Post-COVID Clinical Trial Decentralization
Prior to COVID, major technological transformation initiatives were already underway at many clinical trial sites, sponsors, and contract research organizations (CROs.) But the move to decentralized trials accelerated dramatically in 2020 and 2021–and it’s not slowing down.
Survey data from WCG Avoca shows that research sites and sponsors expect 89% of clinical trials to qualify as a hybrid, with a mix of decentralized technology and in-person visits.
But what will these
Read More
Mayo Clinic Partners with VUNO to Develop AI-Driven Precision Oncology Solutions
What You Should Know:
- Mayo Clinic has signed a research agreement with VUNO, a global medical artificial intelligence (AI) company to develop advanced AI-driven precision oncology solutions to deliver precision oncology care.
- Through this research agreement, VUNO will establish a collaboration with Mayo Clinic to develop innovative AI and machine learning solutions for more precise diagnosis, prognosis and treatment stratification in cancer.
- This collaborative agreement combines
Read More
Reify Health Secures $220M to Support Clinical Trial Diversity at $4.8B Valuation
What You Should Know:
- Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D funding round dedicated to improving diversity in clinical research. The investment comes less than a year after its Series C and brings the company's valuation to $4.8B.
- The Series C found was co-led by Altimeter Capital and Coatue, joined by Dragoneer Investment Group and existing investors ICONIQ Growth, Adams Street, and Battery
Read More
Seven Bridges, USP, Google Cloud to Build A Brazilian Reference Genome
What You Should Know:
- Seven Bridges, a bioinformatics ecosystem provider, announced it is collaborating with the University of São Paulo (USP) and Google Cloud, as well as the Associação Genomas Brasil (Brazil Genome Association), to assist the DNA do Brasil (DNABr) project in building a reference genome that represents the genetic diversity of the Brazilian population.
- The joint effort will advance unbiased precision medicine for underrepresented populations in Brazil through the
Read More
PreciseDx’s AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson’s Disease
What You Should Know:
- Mount Sinai spinout, PreciseDx, today announced that its AI-enabled digital pathology is the first proven to detect early-stage Parkinson’s disease, according to a recent research study.
- The study, conducted in collaboration with Michael J. Fox Foundation, identified that PreciseDx’s technology can accurately diagnose Parkinson's disease in living patients prior to the severe onset of symptoms.
Challenges Diagnosing Parkinson’s
Read More
THREAD Acquires Clinical Trial Recruitment Solution CureClick
What You Should Know:
- THREAD, a technology and consulting service provider enabling electronic clinical outcome assessments and decentralized clinical trials has acquired CureClick, which offers the world’s first proprietary crowdsourcing platform designed to accelerate awareness and participation in clinical research. This acquisition follows THREAD’s recent acquisitions of Modus Outcomes and inVibe, positioning THREAD as the industry’s leading
Read More
Salignostics Raises $8M for Rapid Saliva-Based Test Kits That Detect Pregnancy, COVID-19, Cardiac Risk, and Malaria
What You Should Know:
- Israeli startup Salignostics, the developer and provider of rapid saliva-based tests for early pregnancy detection, as well as COVID-19, cardiac risk, malaria, and other diseases, has closed an $8 million Series A funding round from private investors headed by angel investor Avigdor Orlinsky.
- The company has raised $16M to date to support development, commercialization, and marketing efforts for the tests in Israel and overseas. It will also support the launch of
Read More
DaVita to Invest $15M in Biopharma Company Rockwell Medical
What You Should Know:
- Rockwell Medical, a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management expands its partnership with kidney care leader DaVita Inc. Rockwell Medical has been working to revise certain terms of its supply contracts with customers in an effort to stabilize its concentrates business.
- The amended supply agreement is designed to enable Rockwell Medical's concentrates business the potential to operate
Read More
